Calamos Advisors
CBPO

Calamos Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Calamos Advisors’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-29,580
Closed -$3.18M – 670
2016
Q4 		$3.18M Sell
29,580
-22,605
-43% -$2.64M 0.03% 413
2016
Q3 		$6.5M Sell
52,185
-12,400
-19% -$1.46M 0.05% 323
2016
Q2 		$6.87M Buy
64,585
+20,955
+48% +$2.43M 0.05% 307
2016
Q1 		$5M Hold
43,630
– – 0.03% 333
2015
Q4 		$6.22M Buy
43,630
+270
+0.6% +$31.2K 0.04% 311
2015
Q3 		$3.9M Buy
+43,360
New +$4.58M 0.03% 378

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Calamos Advisors's CBPO Position: Q1 2017 in Review

Calamos Advisors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2017, closing a stake of 29,580 shares — an estimated $3.18M sold.

Calamos Advisors first reported a position in CBPO in Q3 2015 and held it in 6 quarters. The position peaked at $6.87M in Q2 2016. 137 funds tracked by Wall St. Rank hold CBPO as of Q1 2017.

  • Calamos Advisors reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2017 after selling out during the quarter.
  • Calamos Advisors sold 29,580 China Biologic Products Holdings, Inc. shares in Q1 2017, an estimated $3.18M.
  • Calamos Advisors first reported a position in China Biologic Products Holdings, Inc. in Q3 2015 and held it in 6 quarters.
  • Calamos Advisors's China Biologic Products Holdings, Inc. position peaked at $6.87M in Q2 2016.
  • 137 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2017.

Based on Calamos Advisors's 13F filing for Q1 2017, filed 20 Apr 2017.